The aims of this review were to assess smoking prevalence among drug abuse treatment staff and to summarize the range of barriers, as reported by program staff and directors, to provision of nicotine dependence intervention to clients receiving addictions treatment. Smoking prevalence among substance abuse counselors, based on estimates reported in 11 papers, ranged from 14% to 40%. Discounting studies with the lowest response rates (
McDonald, Roberts & Descheemaeker 2000;
Hahn, Warnick & Plemmons 1999) does not change this range. The range of staff smoking rates reported across studies suggests that smoking prevalence is not elevated uniformly in the drug abuse treatment workforce, but may be elevated in some settings or types of settings. Specifically, articles reporting the lowest staff smoking rates (14%) appear to have included staff with higher educational and professional training. In
Hurt and colleagues’ study (1995) 68% of participants were physicians or registered nurses, while
Patten and colleagues (1999) described the staff as including “civilians, Naval officers, physicians, counselors, psychologists, social workers, student interns, and support staff.” The remaining articles reported staff smoking rates in the range from 22% to 40%, and we suggest that this range offers a simple guide to evaluate staff smoking prevalence within any given program. Any program with staff smoking prevalence near 40% is at the highest prevalence observed in the literature in over 20 years. Another strategy for evaluating smoking prevalence rates in any given program is to compare the program prevalence rate to state and national rates (
Bobo & Davis 1993b;
Walsh et al. 2005b).
Regarding the range of barriers to provision of nicotine dependence intervention in addictions treatment settings, three barriers were prominent in this review. These were lack of staff knowledge or training related to nicotine dependence treatment, that smoking cessation concurrent with other drug or alcohol treatment may create a risk to sobriety, and that many staff are themselves smokers. Lack of knowledge and training was reported as a barrier to smoking cessation treatment in a variety settings, including VA programs (
Willenbring et al. 2004), methadone clinics (
McCool, Richter & Choi 2005), and by both clinic leaders (
McCool, Richter & Choi 2005;
Knapp et al. 1993) and staff (
Gill & Bennett 2000;
Hahn, Warnick & Plemmons 1999;
Bobo, Slade & Hoffman 1995) in the U.S., and Australia (
Walsh et al. 2005b). This most widely reported barrier is of interest because studies have found that an increase in staff knowledge or training resulted in a higher provision of (
Bobo, Slade & Hoffman 1995) or a difference in staffs’ attitudes towards (
Gill & Bennett 2000) smoking cessation treatment. The belief that smoking cessation concurrent with other addictions treatment may represent a risk to sobriety is common in the treatment field, and echoes the traditional guideline that persons beginning sobriety should avoid other major life changes for at least one year.
Knapp and colleagues (1993), for example, found that 77% of counselors recommended after one year of sobriety as the most appropriate time to address client smoking. The perception of smoking cessation as a risk to sobriety, while appearing frequently in this review, was sometimes endorsed by small proportions of staff: 13% in a study by
Hurt and colleagues (1995) and 20% in one by
Knapp and colleagues (1993). In contrast to the perception of risk to sobriety,
Prochaska, Delucchi and Hall (2004) found that smoking cessation efforts concurrent with addictions treatment was associated with a 25% increase in long-term abstinence from other drugs. The third frequently occurring barrier in this review was that program staff are themselves smokers; we suggest that this barrier is related to elevated prevalence of smoking among staff in some community-based treatment programs.
A key limitation of this work is that the studies reported span a period of more than 20 years, so that both prevalence estimates and barriers may have changed over time. Some of the more recent staff smoking prevalence estimates, however, suggest a range of staff smoking from 22% to 36% (
Olsen et al. 2005;
Walsh et al. 2005b;
Richter et al. 2004). Focusing only on U.S. studies, and in comparison to the 20.9% smoking prevalence among U.S. adults (
CDC 2006), recent estimates are 22% and 31%. These data suggest that smoking rates among community-based drug treatment staff are elevated above that of the general population. Further, prevalence estimates in this review reflect a number of samples, and may be of limited generalizability. The largest samples included 767 counselors surveyed in Nebraska (
Bobo & Davis 1993a) and 408 methadone treatment program directors (
Richter et al. 2004). In the U.S. specifically, and with the exception of the study by
Richter and colleagues (2004), there are no recent, large, regional or national counselor surveys reporting smoking prevalence. These same limitations, related to reliance on multiple small samples and generalizability, relate to the discussions of barriers to providing smoking cessation services. One additional limitation is that reviewing the literature on barriers requires some interpretation. While we applied and described the basis of including barriers in this review, other reviewers applying more or less conservative criteria may identify different barriers or assign to them different levels of importance.
Notwithstanding these limitations, some implications for the field may be drawn. Smoking prevalence is elevated above that of the general population in many studies where it was reported, and staff smoking is a commonly reported barrier to addressing nicotine dependence in addictions treatment settings. However, staff smoking rates are not uniformly elevated. We suggest that treatment settings with higher proportions of medical and professional staff are likely to have lower rates of staff smoking, while community-based treatment programs and especially those that recruit staff from recovering populations are likely to have higher rates of staff smoking. Adolescent treatment programs, consistent with data reported by
McDonald and colleagues (2000) and
Chun and colleagues (2007) may also tend to have lower staff smoking rates compared to other community-based treatment programs. Consequently, individual treatment programs and systems are encouraged to measure staff smoking rates, and to consider them in the context of state and national smoking rates as well as rates reported in the literature when developing nicotine dependence policies or services. Reduction of smoking prevalence in the drug abuse treatment workforce, in addition to enhancing the health of the workforce, will support development and implementation of nicotine dependence services for clients. “No evidence” policies, requiring that staff do not use tobacco during work hours or when representing the treatment facility (
Williams et al. 2005), are complementary to reducing staff smoking as they remove smoking cues from the client-counselor relationship and may encourage counselors to assess their own nicotine dependence. Second, as a prominent barrier to better addressing nicotine dependence in addiction treatment programs, lack of staff training and knowledge has a practical remedy in the form of staff training. This may include general education for all counselors about nicotine as an addictive drug, and more specialized training to build a cadre of counselors who can provide cessation services to clients. Such training, at the treatment program and system level, has other benefits as well. It can address counselor beliefs that quitting smoking impedes sobriety, that treating other addictions is more important than treating nicotine addiction, or that smoking is helpful to clients in their recovery from other drug use. Last, we (along with others) suggest: (a) dissemination of clinical guidelines for smoking treatment to all certified substance abuse counselors; (b) that states consider mandatory counselor continuing education on smoking cessation (
Hahn, Warnick & Plemmons 1999); (c) that funding be targeted to support reimbursement for smoking cessation intervention for clients; and (d) that resources be developed to enable treatment of smoking among staff (
McCool, Richter & Choi 2005). These steps require not only the efforts of treatment programs and local treatment systems, but collaboration between state departments of alcohol and drug treatment and national and professional organizations in the development of policy guidelines for treatment of nicotine dependence in drug abuse treatment settings (
Walsh et al. 2005b;
Hahn, Warnick & Plemmons 1999).